Lakefront Biotherapeutics NV (LKFT) — Financial Flexibility Index
Lakefront Biotherapeutics NV (LKFT) has a Financial Flexibility Index of -0.39x as of June 2026. Free cash flow of $-34.06 Million (operating CF $-34.09 Million minus capex $29.00K) represents 0% of total liabilities ($87.52 Million). Check LKFT asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lakefront Biotherapeutics NV Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Lakefront Biotherapeutics NV across 4 annual periods. Explore LKFT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Financial Flexibility Index for Lakefront Biotherapeutics NV (2022–2025)
Year-by-year free cash flow to debt coverage for Lakefront Biotherapeutics NV. For the full cash flow conversion analysis, see LKFT cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.43x | $-243.60 Million | $-257.46 Million | $170.65 Million | ▼ -643.3% |
| 2024 | -0.19x | $-237.92 Million | $-320.03 Million | $1.24 Billion | ▲ +22.4% |
| 2023 | -0.25x | $-386.70 Million | $-405.97 Million | $1.56 Billion | ▼ -17.9% |
| 2022 | -0.21x | $-463.60 Million | $-500.54 Million | $2.21 Billion | — |